Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06289452 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Safety and Efficacy Study of IVB102 Injection in Subjects With X-linked Retinoschisis

StatusActive, Not Recruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 30, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v3
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Mar 6, 2024 to Mar 8, 2024
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial is to evaluate the safety and efficacy of IVB102 injection in subjects with XLRS.
Trial Details
NCT Number NCT06289452
Lead Sponsor InnoVec Biotherapeutics Inc.
Collaborators: Peking Union Medical College Hospital
Conditions
(from sponsor)		 Retinoschisis, Retinal Disease, Retinal Degeneration, Eye Diseases
Related terms Eye Diseases, Retinal Degeneration, Retinal Diseases, Retinoschisis
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov